HOME
ABOUT THE COMPANY
Company Overview
Message from CEO
Management Team
Enterprise Video
INNOVATION
Pipeline
Focus Areas
Commercialized products
INVESTORS
Fact Sheet
Corporate Governance
Public Disclosure
Financial Report
Announcements and Circulars
Presentations and Webcasts
IR Contact
Analyst List
MEDIA
CONTACT
Contact
Career
菜单
中文
|
EN
HOME
ABOUT THE COMPANY
Company Overview
Message from CEO
Management Team
Enterprise Video
Innovation
Innovation
Pipeline
Focus Areas
Commercialized products
INVESTORS
Fact Sheet
Corporate Governance
Financial Report
Announcements and Circulars
Presentations and Webcasts
Analyst List
IR Contact
MEDIA
CONTACT
Contact
Career
欧康维视提示
This content is intended for medical professionals only. If you are a medical professional, click to enter the page; otherwise, click Exit to return to the previous page.
Confirm
Cancel
Home
/
Media
Press Release
Media Report
2021
2022
2021
2020
2019
2018
2021-08-21
欧康维视发布半年报:亏损大幅收窄96% 核心产品OT-401获批在即
2021-07-17
全球首个眼内术后炎症缓释新药Dexycu在博鳌乐城完成首例注射!
2021-03-19
欧康维视发布2020年年报,眼科新药Ⅲ期临床试验数国内第一,公司经调整亏损2.77亿元
Follow us